Delhi HC Bars Shilpa Medicare From Making, Selling Ruxolitinib Drugs in Patent Row Susmita Roy1 Jan 2026 6:14 PM ISTNew Delhi: Shilpa Medicare has received an ex-parte ad-interim injunction order from the Delhi High Court, restraining the company and its...
Breaking News: Health Ministry Bans Immediate-Release Nimesulide Oral Doses Above 100 mg Farhat Nasim31 Dec 2025 11:10 AM ISTNew Delhi: The Union Health Ministry has prohibited the manufacture, sale and distribution of all oral formulations of nimesulide containing more than...
Triple Identity Case: Delhi HC Bans Infringing Sun Pharma's PEPFIX-DSR, MINOZIL Marks Susmita Roy30 Dec 2025 4:20 PM ISTNew Delhi: The Delhi High Court has granted a summary judgment in favor of Sun Pharmaceutical Industries, permanently restraining Oziel...
Serum Institute to Get NPPA Nod to Discontinue Two Pack Sizes of Tetanus Toxoid Vaccine Susmita Roy29 Dec 2025 11:04 PM ISTNew Delhi: In a significant regulatory development, the pricing authority, the National Pharmaceutical Pricing Authority (NPPA) has decided not to...
Import Nod on Hold Over False Positives, Tissue Detection: CDSCO Panel Seeks More Data on Medtronic's PTeye Device Susmita Roy28 Dec 2025 5:00 PM ISTNew Delhi: Responding to India Medtronic Private Limited's proposal seeking permission to import and market the medical device "PT Eye Parathyroid...
NPPA Fixes Retail Prices of 37 Drug Formulations Including Atorvastatin, Ezetimibe, Telmisartan, Details Susmita Roy27 Dec 2025 10:08 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Liv.72 Too Close to Liv.52: Calcutta HC Bars Shimla Drugs from Selling Product Imitating Himalaya Susmita Roy26 Dec 2025 9:41 PM ISTNew Delhi: The Calcutta High Court has passed an interim injunction in a trademark infringement and passing-off suit filed by Himalaya Global Holdings...
Abbott's Vildagliptin SR Secures CDSCO Panel Nod on Post-Marketing Safety Data Susmita Roy25 Dec 2025 7:32 PM ISTNew Delhi: Abbott Healthcare has received a positive regulatory outcome after presenting the Active Post-Marketing Surveillance (PMS) study report for...
Fortis Arm Challenges Rs 7 Cr GST Demand: Delhi HC to Decide Tax on Inpatient Medicines Susmita Roy24 Dec 2025 7:09 PM ISTThe tax authorities alleged that the hospital collected GST on medicines and consumables billed at MRP to patients but failed to deposit the same with...
State Drug Alert: 141 Medicine Samples Including Mankind's Telmisartan Fail CDSCO Quality Tests in November Susmita Roy23 Dec 2025 10:13 PM ISTNew Delhi: Reflecting continuing concerns over medicine quality in India's pharmaceutical supply chain, the Central Drugs Standard Control...
CDSCO Flags Popular Pantoprazole, Telmisartan Batches as Spurious in November Alert Susmita Roy22 Dec 2025 4:01 PM ISTNew Delhi: In a development that underscores growing concerns over counterfeit medicines in the supply chain, the Central Drugs Standard Control...
Calcutta High Court Quashes Blacklisting of Helax Healthcare Susmita Roy21 Dec 2025 5:30 PM ISTThe action was taken in connection with the supply of Telmisartan Tablet IP 40 mg under a state government tender.
